RSM logo
Journal of Medical Screening

Home Current issue Browse archive Alerts About the journal Feedback
 
J Med Screen 2008;15:76-82
doi:10.1258/jms.2008.007110
© 2008 Medical Screening Society
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Trevena, L. J
Right arrow Articles by Barratt, A.
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Articles

Randomized trial of a self-administered decision aid for colorectal cancer screening

Lyndal J Trevena, Senior Lecturer  , School of Public Health, University of Sydney, Sydney, Australia

Les Irwig, Professor , School of Public Health, University of Sydney, Sydney, Australia

Alexandra Barratt, Associate Professor , School of Public Health, University of Sydney, Sydney, Australia

Correspondence to: Lyndal Trevena, Room 321b, Edward Ford Building (A27), University of Sydney NSW 2006, Australia; lyndalt{at}health.usyd.edu.au


Objective Previous studies have not assessed whether evidence-based information about the outcomes of colorectal cancer screening increases informed choice among people from a range of socioeconomic backgrounds nor have they assessed whether this can be administered away from a health-care provider.

Methods Randomized controlled trial in six primary care locations. Three hundred and fourteen people aged 50–74 years received a self-administered decision aid (DA) booklet about outcomes of biennial faecal occult blood testing (FOBT) screening or government consumer guidelines (G).

Results Significantly more DA recipients (20.9%) were ‘informed’ compared with G recipients (5.8%) (P = 0.0001, OR 4.32; 95% CI 2.49 to 7.52); the DA did not affect values clarity (61.9% clear after DA versus 59.1% after G) nor screening decisions overall (87.3% would screen after DA versus 90.5% after G). Test uptake at one month was uniformly low (5.2% DA versus 6.6% G); mostly due to being ‘too busy’. DA recipients were more likely to make decisions ‘integrating’ knowledge with values (10.4% DA versus 1.5% G). Decisions not to screen were equally uncommon in both groups but more likely to be uninformed in G (P = 0.03). More DA recipients from all education levels were ‘informed’ (P = 0.02), particularly in lower education (50.0% DA versus 17.8% G) and university-educated groups (79.4% DA versus 32.1% G).

Conclusion Detailed absolute risk and benefit information about FOBT screening can be effectively used at home by people to increase informed choice. The DA was effective in people with lower education levels.

Trial Registration Unique Protocol ID 211705 ClinicalTrials.gov ID NCT 00148226.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Walking London's Medical History